Company page

Aridis Pharmaceuticals Inc.

Aridis Pharmaceuticals Inc. is a public company traded under the ticker ARDS in the American market, with a market capitalization of approximately $138.2 million. The company focuses on developing innovative therapies to combat serious infections and other diseases. Aridis aims to address unmet medical needs through its advanced research and development efforts.